Data / Form D filings / Episteme Prognostics, Inc.
Episteme Prognostics, Inc.: Form D filings
Episteme Prognostics, Inc., a biotechnology company in Brooklyn, NY, filed 6 Form D notices with the SEC between 2022 and 2026. The latest, on September 4, 2026, reports $5.1 million sold of a $6 million offering to 14 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 760 Parkside Avenue Suite 227C, Brooklyn, NY, 11226
- Phone
- 1(929)-400-3308
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1902402
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 4, 2026 | Amendment | $6,017,000 | $5,091,997 | $925,003 | 14 | Aug 20, 2026 | sec.gov |
| Sep 4, 2026 | New notice | $6,017,000 | $5,091,997 | $925,003 | 22 | Aug 20, 2026 | sec.gov |
| Mar 10, 2025 | New notice | $2,500,000 | $550,000 | $1,950,000 | 1 | Feb 21, 2025 | sec.gov |
| May 22, 2023 | Amendment | $4,111,039 | $4,111,039 | 16 | Mar 31, 2023 | sec.gov | |
| Apr 14, 2023 | New notice | $3,701,047 | $3,136,041 | $565,006 | 14 | Mar 31, 2023 | sec.gov |
| Jan 3, 2022 | New notice | $3,000,000 | $80,000 | $2,920,000 | 5 | Dec 15, 2021 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Surajit Dhara | Executive Officer, Director | Chief Executive Officer |
| Gregory Ho | Director | |
| Jason Rifkin | Director |
Other biotechnology companies in New York that filed recently
- Swep Bio, Inc. $2.5 million · Oct 29, 2026
- Hypercell Technologies Inc. $3 million · Oct 14, 2026
- CAD Therapeutics, Inc. $4 million · Oct 2, 2026
- Vicora, Inc. $2.3 million · Sep 18, 2026
- GevRx Nutraceuticals, Inc. $300,000 · Sep 18, 2026
Every Form D from the week of Aug 31, 2026 · All recent filings in New York · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Episteme Prognostics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.